190 related articles for article (PubMed ID: 27481339)
1. Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions.
Sugimoto K; Miyata Y; Nakayama T; Saito S; Suzuki R; Hayakawa F; Nishiwaki S; Mizuno H; Takeshita K; Kato H; Ueda R; Takami A; Naoe T
Sci Rep; 2016 Aug; 6():30779. PubMed ID: 27481339
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression.
Yoon KA; Son Y; Choi YJ; Kim JH; Cho JY
Cell Commun Signal; 2017 Jun; 15(1):25. PubMed ID: 28662672
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration.
Yoon KA; Cho HS; Shin HI; Cho JY
Stem Cells Dev; 2012 Dec; 21(18):3391-402. PubMed ID: 22827607
[TBL] [Abstract][Full Text] [Related]
4. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
6. Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations.
Traer E; Javidi-Sharifi N; Agarwal A; Dunlap J; English I; Martinez J; Tyner JW; Wong M; Druker BJ
Blood; 2014 Mar; 123(10):1516-24. PubMed ID: 24408322
[TBL] [Abstract][Full Text] [Related]
7. FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.
Nakayama T; Mutsuga N; Tosato G
Blood; 2007 Feb; 109(4):1363-72. PubMed ID: 17077327
[TBL] [Abstract][Full Text] [Related]
8. FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.
Hatch NE; Li Y; Franceschi RT
J Bone Miner Res; 2009 Apr; 24(4):652-62. PubMed ID: 19049325
[TBL] [Abstract][Full Text] [Related]
9. Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia.
Tian C; Li Y; Wang L; Si J; Zheng Y; Kang J; Wang Y; You MJ; Zheng G
Cell Death Dis; 2022 Nov; 13(11):922. PubMed ID: 36333298
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.
Fei Y; Xiao L; Doetschman T; Coffin DJ; Hurley MM
J Biol Chem; 2011 Nov; 286(47):40575-83. PubMed ID: 21987573
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factors 1 and 2 inhibit adipogenesis of human bone marrow stromal cells in 3D collagen gels.
Le Blanc S; Simann M; Jakob F; Schütze N; Schilling T
Exp Cell Res; 2015 Nov; 338(2):136-48. PubMed ID: 26384550
[TBL] [Abstract][Full Text] [Related]
12. Induction of an osteocyte-like phenotype by fibroblast growth factor-2.
Gupta RR; Yoo DJ; Hebert C; Niger C; Stains JP
Biochem Biophys Res Commun; 2010 Nov; 402(2):258-64. PubMed ID: 20934405
[TBL] [Abstract][Full Text] [Related]
13. Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment.
Li W; Ding Q; Ding Y; Lu L; Wang X; Zhang Y; Zhang X; Guo Q; Zhao L
Mol Carcinog; 2017 Mar; 56(3):863-876. PubMed ID: 27533597
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stromal dysfunction in mice administered cytosine arabinoside.
Ben-Ishay Z; Barak V
Eur J Haematol; 2001 Apr; 66(4):230-7. PubMed ID: 11380602
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
17. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.
Javidi-Sharifi N; Martinez J; English I; Joshi SK; Scopim-Ribeiro R; Viola SK; Edwards DK; Agarwal A; Lopez C; Jorgens D; Tyner JW; Druker BJ; Traer E
Elife; 2019 Feb; 8():. PubMed ID: 30720426
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.
Xiao L; Sobue T; Esliger A; Kronenberg MS; Coffin JD; Doetschman T; Hurley MM
Bone; 2010 Aug; 47(2):360-70. PubMed ID: 20510392
[TBL] [Abstract][Full Text] [Related]
19. Endogenous FGF-2 is critically important in PTH anabolic effects on bone.
Sabbieti MG; Agas D; Xiao L; Marchetti L; Coffin JD; Doetschman T; Hurley MM
J Cell Physiol; 2009 Apr; 219(1):143-51. PubMed ID: 19107841
[TBL] [Abstract][Full Text] [Related]
20. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
Okada Y; Montero A; Zhang X; Sobue T; Lorenzo J; Doetschman T; Coffin JD; Hurley MM
J Biol Chem; 2003 Jun; 278(23):21258-66. PubMed ID: 12665515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
